Incredo has raised $30 million in Series C funding to advance its innovative sugar reduction technology, aiming to reduce sugar content in food by 30% to 50% without compromising taste.
Target Company Overview
Incredo is a pioneering company focused on revolutionary sugar alternatives, specifically designed to bind real cane or beet sugar with a natural carrier. This innovative technology allows for a reduction of sugar in food products by 30% to 50%, maintaining the same taste, texture, and mouthfeel without altering the original ingredients. This capability offers significant benefits for consumers looking to minimize sugar intake while enjoying their favorite foods.
Since Ari Melamud took over as CEO in 2021, Incredo has successfully transitioned its flagship product, Incredo Sugar, to commercial availability. This progress includes a recent Series C funding round, where Incredo raised $30 million, bringing its total fundraising efforts since its Series B round in 2019 to $60 million.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The sugar replacement industry has faced both challenges and opportunities, particularly as consumer awareness rises regarding sugar consumption and health risks associated with sugary diets. The World Health Organi
Similar Deals
Eshbal Functional Food Inc. → Dare to be Different Foods, Inc.
2025
Constellation Brands, Inc. → The Wine Group
2025
Essity → Edgewell Personal Care’s feminine care business
2025
DSM-Firmenich Venturing and Sienna Venture Capital
invested in
Incredo
in 2023
in a Other deal
Disclosed details
Transaction Size: $30M